Posted by Michael Wonder on 29 Mar 2022
Tarlige tablets approved in Japan for treatment of patients with neuropathic pain
28 March 2022 - Daiichi Sankyo today announced that it has obtained approval in Japan to change the indication of the analgesic Tarlige (mirogabalin besilate) from peripheral neuropathic pain to neuropathic pain.
In May 2021, Daiichi Sankyo submitted a supplemental new drug application for Tarlige based on results from a phase 3 trial in patients with central neuropathic pain.
